Conus medullaris involvement in demyelinating disorders of the CNS: A comparative study

被引:11
|
作者
Etemadifar, Masoud [1 ,2 ]
Salari, Mehri [3 ]
Kargaran, Parisa K. [4 ]
Sigari, Amirhossein Akhavan [2 ]
Nouri, Hosein [2 ,5 ]
Etemadifar, Fatemeh [2 ]
Ebrahimi, Sara [2 ]
Sayahi, Newsha [2 ,6 ]
Sedaghat, Nahad [2 ,5 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Dept Neurosurg, Esfahan, Iran
[2] Isfahan Univ Med Sci, Alzahra Univ Hosp, Alzahra Res Inst, Esfahan, Iran
[3] Shahid Beheshti Univ Med Sci, Dept Neurol Dis, Tehran, Iran
[4] Mayo Clin, Ctr Regenerat Med, Dept Cardiovasc Med, Rochester, MN 55905 USA
[5] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Esfahan, Iran
[6] Islamic Azad Univ, Fac Med, Dept Neurol, Esfahan, Iran
关键词
Demyelinating diseases; Neuromyelitis optica spectrum disorders; Multiple sclerosis; Myelin oligodendrocyte glycoprotein antibody; disorder; Conus medullaris; OLIGODENDROCYTE GLYCOPROTEIN MOG; MYELIN; CRITERIA; AQP4;
D O I
10.1016/j.msard.2021.103127
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Differentiation of the demyelinating disorders of the CNS seems challenging in practice. Conus medullaris, the cone-shaped end of the spinal cord, is more involved in anti-MOG patients based on preliminary studies, a possibly helpful detail in its differentiation. Nevertheless, the evidence is still limited and the underlying cause is unclear and undiscussed in previous studies. Objective: To contribute to preliminary studies by comparing conus involvement among patients with MS, antiAQP4, and anti-MOG diseases using larger sample size. Methods: More than a thousand MS, anti-AQP4, and anti-MOG patients were followed up for a maximum of five years, scanned for conus medullaris involvement. Data regarding each cohort were then analyzed and compared using statistical methods. Results: The rate of conus medullaris involvement was significantly higher in anti-MOG patietns (OR = 27.109, P < 0.001), followed by anti-AQP4 (OR = 4.944, P = 0.004), and MS patients (OR = reference). Survival analysis showed higher pace and cumulative incidence of conus attacks in anti-MOG patients. Conus-involved patients, showed no significant difference regarding age, sex, concurrent brain lesions, and their partial recovery. Predictive values show that the probability of being diagnosed with anti-MOG is roughly 13 times higher in conusinvolved patients (25.93% vs. 1.97%), although this probability was still higher for MS, as it has a much higher incidence. Conclusion: Despite minor differences, the results were in line with previous studies, confirming the higher rate of conus medullaris involvement among anti-MOG patients. Potential underlying causes are proposed and remain to be investigated in future studies.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Understanding metastatic involvement of the conus medullaris: a systematic review of clinical presentations, diagnostic approaches, treatment options, and patient outcomes
    Badary, Amr
    Kertam, Ahmed
    El-Ramly, Toka Aziz
    Abomera, Noura E.
    Salama, Esraa Y.
    Abdelaal, Sondous
    Monib, Fatma
    Hernandez-Hernandez, Alan
    Sanker, Vivik
    Atallah, Oday
    Moustafa, Wahab
    Silbermann, Joerg
    Al-Barbarawi, Mohammad Khalil
    JOURNAL OF NEURO-ONCOLOGY, 2024, 170 (03) : 495 - 507
  • [32] Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
    Banwell, B.
    Tenembaum, S.
    Lennon, V. A.
    Ursell, E.
    Kennedy, J.
    Bar-Or, A.
    Weinshenker, B. G.
    Lucchinetti, C. F.
    Pittock, S. J.
    NEUROLOGY, 2008, 70 (05) : 344 - 352
  • [33] Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
    Pittock, Sean J.
    Tenembaum, Silvia
    Lennon, Vanda A.
    Ursell, Emily
    Kennedy, Julia
    Bar-Or, Amit
    Weinshenker, Brian G.
    Lucchinetti, Claudia F.
    Banwell, Brenda
    ANNALS OF NEUROLOGY, 2007, 62 : S73 - S73
  • [34] Conus medullaris syndrome without lower-extremity involvement in L-1 burst fractures - Report of four cases
    Chou, D
    Hartl, R
    Sonntag, VKH
    JOURNAL OF NEUROSURGERY-SPINE, 2006, 4 (03) : 265 - 269
  • [35] CSF oligoclonal bands in neurological diseases besides CNS inflammatory demyelinating disorders
    Ren, Jingru
    Wang, Jianchun
    Liu, Ran
    Guo, Jing
    Yao, Yan
    Hao, Hongjun
    Gao, Feng
    BMJ NEUROLOGY OPEN, 2025, 7 (01)
  • [36] HMO-IgG status in fulminant CNS inflammatory demyelinating disorders (IDD)
    Magana, Setty M.
    Pittock, Sean
    Lennon, Vanda
    Keegan, Mark
    Weinshenker, Brian
    Lucchinetti, Claudia
    NEUROLOGY, 2007, 68 (12) : A160 - A160
  • [37] detection of anti mog antibodies in demyelinating disorders of the central nervous system (CNS)
    Sala, A.
    Spadaro, M.
    Capobianco, M.
    Bertolotto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 687 - 687
  • [38] Inhibiting leukocyte recruitment to the brain by IVIg: is it relevant to the treatment of demyelinating CNS disorders?
    Dalakas, MC
    BRAIN, 2004, 127 : 2569 - 2571
  • [39] Clinical Profile and functional outcomes of idiopathic inflammatory demyelinating disorders of CNS in adults
    Gorthi, Sankar Prasad
    Ranjit, G.
    Chandran, Vijay
    Prabhu, Arvind
    Chatterjee, Aparajita
    NEUROLOGY, 2019, 92 (15)
  • [40] CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease
    Rosenthal, Jacqueline F.
    Hoffman, Benjamin M.
    Tyor, William R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) : 321 - 330